Tulodiv, 600 , 50 , 300 , 600 mg, 50 mg, 300 mg, FC tablets

Tulodiv, 600 , 50 , 300 , 600 mg, 50 mg, 300 mg, FC tablets

S4
PDF Leaflet Revision Date: 17 June 2025


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of HIV infection in adults and adolescents from 18 years.

Dosage (summary)

One tablet once daily for adults and adolescents >40 kg.

Special Populations

  • Renal impairment
  • Hepatic impairment
  • Elderly

Pregnancy & Breastfeeding

Contraindicated in first trimester; use caution in later trimesters; not recommended during breastfeeding.

Key Drug Interactions

  • Metformin contraindicated
  • Avoid with dofetilide and pilsicainide
  • Caution with antacids containing polyvalent cations

Contraindications

  • Hypersensitivity to components
  • Moderate/severe hepatic impairment
  • Creatinine clearance < 50 ml/min

Common side effects

  • Hypersensitivity reactions
  • Nausea
  • Diarrhea
  • Fatigue
  • Rash

Counselling Points

  • Inform about hypersensitivity risks
  • Do not restart after hypersensitivity reaction
  • Regular monitoring of viral load and CD4 counts

Serious warnings

  • Risk of hypersensitivity reactions
  • Potential for lactic acidosis
  • Increased risk of myocardial infarction

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Tulodiv, 600 , 50 , 300 , 600 mg, 50 mg, 300 mg, FC tablets
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW